Marc Cluzel
Chairman at MORPHOSYS AG
Net worth: 603 437 $ as of 2024-04-29
Network origin in Marc Cluzel first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
79
| Public Company | Biotechnology | 79 |
54
| Public Company | Biotechnology | 54 |
Université de Montpellier
13
| College/University | Other Consumer Services | 13 |
Moleac Pte Ltd.
 Moleac Pte Ltd. Pharmaceuticals: MajorHealth Technology Moleac Pte Ltd. develops and distributes biopharmaceutical products. It operates as a bio-pharmaceutical company that develops new medicines for the unmet needs of patients suffering from neurological, cardio-vascular and aging conditions. The firm's flagship product NeuroAiD, helps patients recover faster and better from stroke disabilities. The company was founded by David Picard and Marc Vasseur in 2003 and is headquartered in Singapore.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Marc Cluzel via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| ESSEC Business School | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Ecole Polytechnique | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member President Director/Board Member | |
| Sciences Po | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | President Corporate Officer/Principal Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| VIVENDI SE | Media Conglomerates | Chairman Director/Board Member Corporate Officer/Principal | |
| KERING | Consumer Sundries | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Compliance Officer Comptroller/Controller/Auditor | |
| PFIZER, INC. | Pharmaceuticals: Major | Chairman Public Communications Contact | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
| CAPGEMINI SE | Information Technology Services | Director/Board Member Director/Board Member | |
| Association Française des Entreprises Privées | Director/Board Member Director/Board Member | ||
| Rhone-Poulenc Group | Chief Executive Officer Chief Executive Officer | ||
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Foundation for Innovative New Diagnostics
 Foundation for Innovative New Diagnostics Medical/Nursing ServicesHealth Services Foundation for Innovative New Diagnostics provides healthcare services. It enables the development and delivery of much-needed diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, febrile illnesses and infectious diseases with outbreak potential, such as Ebola. The company was founded in 2003 and is headquartered in Geneva, Switzerland. | Medical/Nursing Services | Chairman Director/Board Member | |
| AXA | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Definiens AG
 Definiens AG Packaged SoftwareTechnology Services Definiens AG is a holding company, which engages in the development and market of biomedical imaging and data analysis software solutions. The firm specializes in the design and manufacture of imaging software suites for drug discovery, development, and diagnostics applications. It engages in the custom image analysis projects for the biopharmaceutical industry, spanning drug discovery, translational research, and clinical research. It offers image analysis processing, integration and deployment, planning, and consulting services. The company was founded by Gerd Binnig in 1994 and is headquartered in Munich, Germany. | Packaged Software | Chairman Director/Board Member | |
| Sorbonne Université | College/University | Doctorate Degree Graduate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Director/Board Member | |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Medical Specialties | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
| ALLIANZ SE | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Chairman Director/Board Member | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree Corporate Officer/Principal | |
French Academy of Sciences
 French Academy of Sciences Other Consumer ServicesConsumer Services French Academy of Sciences engages in protection of spirit of French scientific research. The firm offers science teaching, transmitting knowledge, international collaboration and advice. The company was founded by Jean-Baptiste Colbert in 1666 and is headquartered in Paris, France. | Other Consumer Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree | |
| BAYER AG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| CLINIGEN GROUP PLC | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Aventis Foundation | Director/Board Member Director/Board Member | ||
| Humboldt-Universität zu Berlin | College/University | Doctorate Degree Graduate Degree | |
| École Normale Supérieure | College/University | Director/Board Member Graduate Degree | |
| Institut d'Études Politiques d'Aix-en-Provence | College/University | Graduate Degree Undergraduate Degree | |
| Philipps University of Marburg | College/University | Chairman Doctorate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member President | |
| Johann Wolfgang Goethe-Universität Frankfurt am Main | College/University | Doctorate Degree Doctorate Degree |
Statistics
International
| France | 21 |
| Germany | 14 |
| United States | 11 |
| Switzerland | 5 |
| United Kingdom | 3 |
Sectoral
| Consumer Services | 20 |
| Health Technology | 18 |
| Finance | 4 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operational
| Director/Board Member | 430 |
| Corporate Officer/Principal | 213 |
| Chairman | 170 |
| Independent Dir/Board Member | 100 |
| Chief Executive Officer | 72 |
Most connected contacts
| Insiders | |
|---|---|
| Serge Weinberg | 49 |
| Christopher Viehbacher | 37 |
| Bruno Roger | 36 |
| George Golumbeski | 36 |
| Daniel Camus | 31 |
| Elmar Schnee | 31 |
| Karin Eastham | 29 |
| Gerald Heinz Möller | 29 |
| Robert Castaigne | 23 |
| Wendy Johnson | 23 |
| Jean-René Fourtou | 21 |
| Arthur Charles V. Wellesley | 21 |
| Frank Morich | 21 |
| Thierry Desmarest | 20 |
| Claudie Haigneré | 20 |
- Stock Market
- Insiders
- Marc Cluzel
- Company connections